Aqua Bio Technology ASA
4.89
NOK
0.00
(0.00%)
Aqua Bio Technology ASA
OSL:ABTEC
(Euronext Oslo)
Recent
price
4.89
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
NOK
•
in mil. unless spec.Working Capital
NOK
•
in mil. unless spec.Growth Rates
NOK
•
in mil. unless spec.Semi-annual Revenue
NOK
•
in mil. unless spec.Semi-annual Earnings Per Share
NOK
•
in mil. unless spec.Semi-annual Dividends Per Share
NOK
•
in mil. unless spec.- Similar Companies
- Business
- Aqua Bio Technology ASA is a Norway-based biotechnology and commercial distribution company that researches, develops, and commercializes sustainable bioactive ingredients and personal care products, alongside providing international logistics and e-commerce fulfillment services. The company operates through two core business divisions: Biotechnology and Skincare, and Logistics and Distribution. Its comprehensive product and service portfolio comprises proprietary marine- and botanical-derived cosmetic active ingredients, including Aquabeautine XL (a patented skin renewal and exfoliating enzyme derived from salmon hatching fluid) and Spirulysat (a purified spirulina microalgae antioxidant extract); proprietary and licensed skincare product lines, including Moana-Organic skincare and Cuvget-Arctic skincare formulations; third-party skincare and personal care brand marketing and distribution across retail, dermatological clinic, and professional channels in the Nordic region and broader Europe; cross-border freight forwarding, air shipping, and sea transport services; dedicated e-commerce shipping solutions and package forwarding connecting North American retailers to European consumers through its JetCarrier subsidiary; third-party logistics (3PL) services, automated warehousing, and integrated e-commerce order fulfillment plugins for commercial merchants; and comprehensive international customs clearance and brokerage services. Founded in 2000 and headquartered in Oslo, Norway, Aqua Bio Technology ASA serves cosmetic ingredient manufacturers, pharmaceutical and dermatological distributors, commercial e-commerce retailers, and retail consumers primarily across the Nordic countries, Europe, the Middle East, and North America. In recent developments, the company executed a major strategic expansion by acquiring cross-border logistics and customs specialist JetCarrier AS in late 2024, significantly bolstering its supply chain infrastructure and recurring revenue profile. Following an operational and portfolio review in May 2025, Aqua Bio Technology streamlined its business footprint by divesting retail and distribution subsidiaries Coverbrands AS, Ovalen AS, and 3D Innovation Nordic AS, while discontinuing capital allocation to non-core retail entities including Skinteam Norge AS. To optimize its capital structure and support its ongoing logistics and biotech operations, the company implemented several private placements, subsequent share offerings, and debt-to-equity conversions throughout 2025 and 2026.